Publications

Title

Author

Year

Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy.

D'Ancona, F; Salmaso, S; Barale, A; BOCCIA, D; Lopalco, PL; Rizzo, C; Monaco, M; Massari, M; Demicheli, V; Pantosti, A; Italian PNC-Euro working group,;

2005

Vaccine, (2005).23 19 10.1016/j.vaccine.2004.10.037.

MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain.

Oster, P; Lennon, D; O'Hallahan, J; MULHOLLAND, K; Reid, S; Martin, D;

2005

Vaccine, (2005).23 17-18 10.1016/j.vaccine.2005.01.063.

From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease.

O'Hallahan, J; Lennon, D; Oster, P; Lane, R; Reid, S; MULHOLLAND, K; Stewart, J; Penney, L; Percival, T; Martin, D;

2005

Vaccine, (2005).23 17-18 10.1016/j.vaccine.2005.01.061.

Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy.

Ameratunga, S; Macmillan, A; Stewart, J; Scott, D; MULHOLLAND, K; Crengle, S; Meningococcal Management Team,;

2005

Vaccine, (2005).23 17-18 10.1016/j.vaccine.2005.01.048.

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.

MANGTANI, P; Roberts, JA; Hall, AJ; Cutts, FT;

2005

International journal of epidemiology, (2005).34 3 10.1093/ije/dyh341.

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Cutts, FT; ZAMAN, SM A; Enwere, G; Jaffar, S; Levine, OS; Okoko, JB; Oluwalana, C; Vaughan, A; Obaro, SK; Leach, A; MCADAM, KP; Biney, E; Saaka, M; Onwuchekwa, U; Yallop, F; Pierce, NF; GREENWOOD, BM; Adegbola, RA; Gambian Pneumococcal Vaccine Trial Group,;

2005

Lancet, (2005).365 9465 10.1016/S0140-6736(05)71876-6.

Malaria vaccine: 3 or 6 months' protection?.

SMITH, PG; MILLIGAN, PJ;

2005

The Lancet, (2005).365 9458 10.1016/s0140-6736(05)17860-x.

Malaria vaccine: 3 or 6 months' protection?.

SMITH, PG; MILLIGAN, PJ;

2005

Lancet, (2005).365 9458 10.1016/S0140-6736(05)17860-X.

Influenza vaccination in Brazil: rationale and caveats.

Da Cunha, SS; Camacho, LA B; SANTOS, AC; Dourado, I;